Article information
Full text is only aviable in PDF
REFERENCES
[1]
MD Lougheed, M Lam, L Furkert, KA Webb, DE O'Donnell.
Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms.
Am Rev Respir Dis, 148 (1993), pp. 1452-1459
[2]
R Pawels, SA Buist, P Calverley, C Jenkins, S Hurd.
Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Workshop summary.
Am J Respir Crit Care Med, 163 (2001), pp. 1256-1276
[3]
BR Celli, W MacNee.
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.
Eur Respir J, 23 (2004), pp. 932-946
[4]
K Nishimura, T Izumi, M Tsukino, T Oga.
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.
Chest, 121 (2002), pp. 1434-1440
[5]
C Casanova, C Cote, JP de Torres, A Aguirre-Jaime, JM Marín, V Pinto-Plata, et al.
The inspiratory to total lung capacity ratio predicts mortality in patients with COPD.
Am J Respir Crit Care Med, 171 (2005), pp. 591-597
[6]
DE O'Donnell.
Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
Proc Am Thorac Soc, 3 (2006), pp. 180-184
[7]
DE O'Donnell, JC Bertley, LK Chau, KA Webb.
Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms.
Am J Respir Crit Care Med, 155 (1997), pp. 109-115
[8]
DE O'Donnell, SM Revill, KA Webb.
Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 164 (2001), pp. 770-777
[9]
O Díaz, C Villafranca, H Ghezzo, G Borzone, A Leiva, J Milic-Emil, et al.
Role of inspiratory capacity on exercise tolerance in COPD patients with and without expiratory flow limitation at rest.
Eur Respir J, 16 (2000), pp. 269-275
[10]
JM Marín, SJ Carrizo, M Gascón, A Sánchez, B Gallego, BR Celli.
Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 163 (2001), pp. 1395-1399
[11]
MF Newton, DE O'Donnell, L Forkert.
Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation.
Chest, 121 (2002), pp. 1042-1050
[12]
B Celli, R ZuWallack, S Wang, S Kesten.
Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
Chest, 124 (2003), pp. 1743-1748
[13]
J Dreyse, F Silva, O Díaz, G Borzone, C Lisboa.
Beneficios clínicos y funcionales de agregar teofilina a la terapia inhalatoria con broncodilatadores de acción corta en pacientes con enfermedad pulmonar obstructiva crónica.
Rev Med Chil, 133 (2005), pp. 1211-1219
[14]
ED O'Donnell, N Voduc, M Fitzpatrick, KA Webb.
Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease.
Eur Respir J, 24 (2004), pp. 86-94
[15]
JA Van Noord, JL Aunmann, E Janssens, J Verhaert, JJ Smeets, A Mueller, et al.
Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
Chest, 129 (2006), pp. 509-517
[16]
ED O'Donnell, F Sciurba, B Celli, DA Mahler, KA Webb, CJ Kalberg, et al.
Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD.
Chest, 130 (2006), pp. 647-656
[17]
J Porszasz, M Emtner, S Goto, A Somfay, BJ Whipp, R Casaburi.
Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD.
Chest, 128 (2005), pp. 2025-2034
[18]
F Gigliotti, C Coli, R Bianchi, M Grazzini, L Stendardi, C Castellani, et al.
Arm exercise and hyperinflation in patients with COPD: effect of arm training.
Chest, 128 (2005), pp. 1225-1232
[19]
ND Eves, SR Petersen, MJ Haykowsky, EY Way, RL Jones.
Helium-hyperoxia exercise and respiratory mechanism in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 174 (2006), pp. 763-771
[20]
S Budweiser, F Heinemann, W Fischer, J Dobroschke, M Pfeifer.
Long-term reduction of hyperinflation in stable COPD by noninvasive nocturnal home ventilation.
Respir Med, 99 (2005), pp. 976-984
[21]
R Neviere, M Catto, N Bautin, S Robin, H Porte, J Desbordes, et al.
Longitudinal changes in hyperinflation parameters and exercise capacity after giant bullous emphysema surgery.
J Thorac Cardiovasc Surg, 132 (2006), pp. 1203-1207
[22]
A Fishman, F Martínez, K Naunheim, S Piantadosi, R Wise, A Ries, et al.
National Emphysema Treatment Trial research group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
N Engl J Med, 348 (2003), pp. 2059-2073
[23]
F Martínez, G Foster, JL Curtis, et al.
NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction.
Am J Respir Crit Care Med, 173 (2006), pp. 1326-1334
[24]
T Oga, K Nishimura, M Tsukino, S Sato, T Hajiro.
Analysis of the factor related to mortality in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 167 (2003), pp. 544-549
[25]
VM Pinto-Plata, C Cote, H Cabral, J Taylor, BR Celli.
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.
Eur Respir J, 23 (2004), pp. 28-33
[26]
C Tantucci, V Pinelli, S Cossi, M Guerini, F Donato, V Grassi, The Sara Study Group.
Reference values and repeatability of inspiratory capacity for men and women aged 65-85.
Resp Med, 100 (2006), pp. 871-877
[27]
AL Albuquerque, LE Neri, DS Villaca, TY Machado, CC Oliveira, AT Paes, et al.
Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III.
Eur Respir J, 28 (2006), pp. 939-944
[28]
CM Parker, N Voduc, SD Aaron, KA Webb, DE O'Donnell.
Physiological changes during symptom recovery from moderate exacerbations of COPD.
Eur Respir J, 26 (2005), pp. 420-428
[29]
NJ Stevenson, PP Walker, RW Costello, PM Calverley.
Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 172 (2005), pp. 1510-1516
[30]
Pinto-Plata V, Livnat G, Cabral H, Masdin P, Linacre P, Watson C, et al. Systemic inflammatory cytokines, clinical and physiologic changes in exacerbation of COPD. Chest. En prensa 2007.
[31]
CM Chu, VL Chan, AWN Lin, IW Wong, WS Leung, CK Lai.
Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure.
Thorax, 59 (2004), pp. 1020-1025
Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
